Serial integrated 18F-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma

Breast Journal

Volumn 13, Issue 4, 2007, Pages 424-425

  Beresford, Mark ^a   Lyburn, Iain ^a,b   Sanghera, Bal ^a   Makris, Andreas ^a   Wong, Wai Lup ^a  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b Linton House Clinic   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUORODEOXYTHYMIDINE F 18; FLUOROURACIL; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MULTIPLE CYCLE TREATMENT; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; TREATMENT RESPONSE;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYCLOPHOSPHAMIDE; DIDEOXYNUCLEOSIDES; DRUG MONITORING; EPIRUBICIN; FEMALE; FLUORINE RADIOISOTOPES; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34250839946     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2007.00454.x     Document Type: Article

References (2)

1. Kenny L, Vigushin D, Al-Nahhas A, et al. Quantification of cellular proliferation in tumour and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. Cancer Res, 2005 65: 10104 12.
2. Burcombe RJ, Makris A, Richman P, et al. Evaluation of ER, PgR, HER-2 and Ki67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. Br J Cancer 2005 92: 147 55.